A simple blood draw helps cancer patients get the right drug.
Soon, it could detect cancer earlier than ever before.
Follow a manual added link
Now FDA Approved
Guardant360® CDx is the first FDA-approved liquid biopsy for comprehensive tumor mutation profiling across all solid cancers.
